loading

Kiniksa Pharmaceuticals International Plc (KNSA) 最新ニュース

pulisher
03:56 AM

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of “Buy” by Analysts - Defense World

03:56 AM
pulisher
03:01 AM

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Rating of "Buy" by Analysts - MarketBeat

03:01 AM
pulisher
12:11 PM

Kiniksa Pharmaceuticals Announces Q2 2025 Financial Results Conference Call. - AInvest

12:11 PM
pulisher
Jul 25, 2025

Cwm LLC Buys 19,828 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Jul 25, 2025
pulisher
Jul 25, 2025

Cwm LLC Has $491,000 Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World

Jul 25, 2025
pulisher
Jul 25, 2025

Cerity Partners LLC Purchases 12,110 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Jul 25, 2025
pulisher
Jul 24, 2025

Kiniksa Pharmaceuticals to Report Second Quarter 2025 Financial Results on July 29, 2025 - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Cerity Partners LLC Boosts Stock Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World

Jul 24, 2025
pulisher
Jul 23, 2025

Kiniksa Pharmaceuticals Ltd. Stock Analysis and ForecastExceptional gains - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

BlackRock, Inc. Significantly Reduces Holdings in Kiniksa Pharmaceuticals International PLC - GuruFocus

Jul 23, 2025
pulisher
Jul 22, 2025

Kiniksa Pharmaceuticals International’s (KNSA) “Outperform” Rating Reaffirmed at Wedbush - Defense World

Jul 22, 2025
pulisher
Jul 20, 2025

Teacher Retirement System of Texas Decreases Stock Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World

Jul 20, 2025
pulisher
Jul 19, 2025

Insider Selling: Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) COO Sells 18,900 Shares of Stock - MarketBeat

Jul 19, 2025
pulisher
Jul 18, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Shares Sold by Rice Hall James & Associates LLC - MarketBeat

Jul 18, 2025
pulisher
Jul 16, 2025

Kiniksa Pharmaceuticals COO Eben Tessari Buys, Sells Shares on July 14 - AInvest

Jul 16, 2025
pulisher
Jul 12, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Shares Bought by GAMMA Investing LLC - Defense World

Jul 12, 2025
pulisher
Jul 12, 2025

Wealth Enhancement Advisory Services LLC Invests $301,000 in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Jul 12, 2025
pulisher
Jul 11, 2025

Kiniksa Pharmaceuticals Surges 7.24% on July 9 Amid Analyst Predictions - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock Price Expected to Rise, Wells Fargo & Company Analyst Says - Defense World

Jul 11, 2025
pulisher
Jul 09, 2025

KNSA: Analyst Maintains Overweight Rating, Raises Price Target | - GuruFocus

Jul 09, 2025
pulisher
Jul 09, 2025

Allspring Global Investments Holdings LLC Sells 439,622 Shares of Dr. Reddy’s Laboratories Ltd (NYSE:RDY) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Allspring Global Investments Holdings LLC Trims Holdings in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Allspring Global Investments Holdings LLC Raises Holdings in Broadstone Net Lease, Inc. (NYSE:BNL) - Defense World

Jul 09, 2025
pulisher
Jul 09, 2025

Wealth Enhancement Advisory Services LLC Purchases New Shares in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World

Jul 09, 2025
pulisher
Jul 06, 2025

Kiniksa Pharmaceuticals: A 7.9 Score and Room for Growth - AOL.com

Jul 06, 2025
pulisher
Jul 05, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Consensus Rating of "Buy" by Analysts - MarketBeat

Jul 05, 2025
pulisher
Jul 04, 2025

Peregrine Capital Management LLC Purchases 65,147 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Jul 04, 2025
pulisher
Jul 02, 2025

Asset Management One Co. Ltd. Makes New $41,000 Investment in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World

Jul 02, 2025
pulisher
Jun 29, 2025

AMI Asset Management Corp Has $1.73 Million Position in Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Jun 29, 2025
pulisher
Jun 27, 2025

Genentech ends ulcerative colitis study for drug from $700 million dealSan Francisco Business Times - The Business Journals

Jun 27, 2025
pulisher
Jun 22, 2025

GAMMA Investing LLC Purchases 26,826 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - MarketBeat

Jun 22, 2025
pulisher
Jun 21, 2025

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) COO Eben Tessari Sells 17,300 Shares - MarketBeat

Jun 21, 2025
pulisher
Jun 19, 2025

Rhumbline Advisers Acquires 3,745 Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) - Defense World

Jun 19, 2025
pulisher
Jun 18, 2025

Kiniksa pharma COO Tessari sells $489k in shares By Investing.com - Investing.com South Africa

Jun 18, 2025
pulisher
Jun 16, 2025

Kiniksa Pharmaceuticals: Arcalyst Performs, KPL-387 Advancing Fast (NASDAQ:KNSA) - Seeking Alpha

Jun 16, 2025
pulisher
Jun 13, 2025

Lewis & Ellis acquires Huggins Actuarial Services - Yahoo

Jun 13, 2025
pulisher
Jun 13, 2025

UK court rules insurers must pay more than $1bn for planes seized in Russia - Yahoo

Jun 13, 2025
pulisher
Jun 13, 2025

Payment software firm Payrails raises $32m in funding - Yahoo

Jun 13, 2025
pulisher
Jun 13, 2025

WRAP EU leads textiles extended producer responsibility talks - Yahoo

Jun 13, 2025
pulisher
Jun 13, 2025

Canary raises $80m to fuel expansion in hospitality AI - Yahoo

Jun 13, 2025
pulisher
Jun 13, 2025

FirmaPak expands global footprint with Lighthouse Packaging acquisition - Yahoo

Jun 13, 2025
pulisher
Jun 13, 2025

FDA approves label expansion of AbbVie hepatitis C therapy - Yahoo

Jun 13, 2025
pulisher
Jun 13, 2025

Israel attacks Iran, stock market futures tumble - Yahoo

Jun 13, 2025
pulisher
Jun 12, 2025

Green Bay Packaging Executive Vice President Bryan Hollenbach to retire in August - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

Jio BlackRock gets nod to operate as investment adviser in India - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

Output of key food commodities “on course for new records” – FAO - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

Why Oklo Stock Dropped on Thursday - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

Medtech leaders unite on Capitol Hill to fight tariffs - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

Actabl launches new ProfitSword digital night audit feature for hotels - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

UCC Holding and Ashghal launch 3D Printed Schools Project in Qatar - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

Grant Thornton Advisors appoints new COO - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

Biggby Coffee unveils first brand refresh - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

Prime Drink Group’s bottling unit enters receivership - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

Del Taco expands to Louisville with new franchise agreement - Yahoo

Jun 12, 2025
pulisher
Jun 12, 2025

Trump’s Treasury Sec Admits It’s Another TACO Day With China - Yahoo

Jun 12, 2025
pulisher
Jun 11, 2025

Hakkers and Paebbl introduce carbon-storing solution at Port of Rotterdam - Yahoo

Jun 11, 2025
pulisher
Jun 11, 2025

Mistral unveils Europe’s first AI reasoning model Magistral - Yahoo

Jun 11, 2025
pulisher
Jun 10, 2025

Costco Announces Important Change for Certain Members Starting June 30 - Yahoo

Jun 10, 2025
pulisher
Jun 10, 2025

Transcript : Kiniksa Pharmaceuticals International, plc Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 08 - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

MSD receives FDA approval for Enflonsia to prevent RSV - Yahoo

Jun 10, 2025
pulisher
Jun 05, 2025

Kiniksa Pharmaceuticals Executives Sell Shares - TradingView

Jun 05, 2025
pulisher
Jun 05, 2025

KNSA stock soars to 52-week high, hits $29.71 amid robust gains - Investing.com UK

Jun 05, 2025
pulisher
Jun 05, 2025

Kiniksa sets Phase 2/3 trial for heart drug KPL-387 - Investing.com Nigeria

Jun 05, 2025
pulisher
Jun 05, 2025

Kiniksa (KNSA) to Launch Phase 2/3 Trial for KPL-387 in 2025 | K - GuruFocus

Jun 05, 2025
pulisher
Jun 05, 2025

Kiniksa Pharmaceuticals Announces Trial Design Of Planned Phase 2/3 Clinical Trial Of Kpl-387 In Recurrent Pericarditis - marketscreener.com

Jun 05, 2025
$72.93
price up icon 2.82%
$14.92
price up icon 1.57%
$9.41
price up icon 0.64%
drug_manufacturers_specialty_generic RDY
$14.67
price down icon 0.27%
$132.14
price up icon 0.38%
$304.50
price down icon 0.62%
大文字化:     |  ボリューム (24 時間):